Jan 8 (Reuters) - Windtree Therapeutics Inc ( WINT ):
* WINDTREE THERAPEUTICS ANNOUNCES NEW CORPORATE STRATEGY
SEEKING
TO IDENTIFY AND ACQUIRE FDA-APPROVED REVENUE ASSETS WHILE
ADVANCING ITS CARDIOVASCULAR AND ONCOLOGY PIPELINE
* WINDTREE THERAPEUTICS INC ( WINT ) - TO ACQUIRE STRATEGIC
SUBSIDIARIES
WITH FDA-APPROVED PRODUCTS
* WINDTREE THERAPEUTICS INC ( WINT ) - TO USE EQUITY FOR ACQUISITIONS
Source text:
Further company coverage: